Pfizer Submits Favorable Initial Data To The FDA On Kids’ COVID-19 Vaccine Trial : Coronavirus Updates : NPR

Pfizer and BioNTech say they will submit a formal request for emergency use authorization of the vaccine in young children “in the coming weeks,” as they share data with the FDA about trials for kids from 5 up to 12. Here, a healthcare worker administers a dose of the vaccine to an older child at…